Alan T. Remaley

Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer

Raffit Hassan, Alan T. Remaley, Maureen Sampson et al. · Clinical Cancer Research · 2006 · 286 citations

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

Michel R. Langlois, Børge G. Nordestgaard, Anne Langsted et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2019 · 192 citations · Full text

Hypertension, Consensus-based Recommendations, Hyperlipidemia +18

Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation

Ana C. P. Souza, Alexander V. Bocharov, Irina N. Baranova et al. · Kidney International · 2016 · 70 citations · Full text

Hypertension, Renal Function, Sodium Homeostasis +12

Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case–control study

Evgenia Gourgari, Junfeng Ma, Martin P. Playford et al. · Cardiovascular Diabetology · 2019 · 60 citations · Full text

The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States

Beverley Adams‐Huet, Rafael Zubirán, Alan T. Remaley et al. · Journal of clinical lipidology · 2024 · 38 citations

Insulin Resistance, Obesity, Metabolic Syndrome +10